在加拿大安大略省,比较处方更安全的阿片类药物供应和美沙的影响:基于人口的匹配队列研究
Tara Gomes1, Daniel McCormack2, Gillian Kolla3
1ICES, Toronto, ON, Canada; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada; MAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, ON, Canada; Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
The Lancet. Public health
|April 25, 2025
概括
更安全的阿片类药物供应 (SOS) 计划和甲治疗都改善了患者的健康结果. 在SOS计划中,除了传统的阿片类药物激动剂治疗之外,还提供了一种补充性降低危害的策略.
科学领域:
- 公共卫生 公共卫生
- 药理学 药理学是指药理学的学科.
- 成 药物 药物 药物 药物
背景情况:
- 处方更安全的阿片类药物供应 (SOS) 计划代表了新的危害减少干预措施.
- 与接受甲的人相比,接受SOS的个体的健康结果被检查.
研究的目的:
- 评估与处方安全阿片类药物供应 (SOS) 计划相关的健康结果和医疗保健成本.
- 为了将这些结果与接受甲治疗的个人进行比较.
主要方法:
- 在加拿大安大略省进行基于人口的队列研究 (2016年1月至2021年12月).
- 根据人口统计和倾向得分,将856名新的SOS接受者与856名新的甲接受者 (1:1) 相匹配.
- 使用中断时间序列和回归分析,在一年内评估主要结果,包括阿片类毒性,急诊室访问,住院,感染和医疗保健费用.
主要成果:
- 团体内部分析显示,SOS接收者在阿片类毒性,急救诊所访问,住院治疗,感染和医疗保健费用方面有显著改善.
- 组间分析表明,与甲相比,SOS发起者存在较高的阿片类毒性风险,急救诊所访问和住院住院风险.
- 与甲接收者相比,SOS接收者不太可能停止治疗.
结论:
- SOS和美沙都与改善的健康结果和减少治疗开始后一年的医疗保健利用有关.
- SOS计划是传统阿片类药物激动剂治疗的重要补充选择,扩大了物质使用障碍患者的护理选择.
相关概念视频
Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.


